Can I read HCC Detection: GALAD vs. Doylestown Plus on EtoBox?

HCC Detection: GALAD vs. Doylestown Plus by oviedomauricio02 is a document available to read on EtoBox.

What is HCC Detection: GALAD vs. Doylestown Plus about?

The study evaluates the effectiveness of two novel biomarker panels, Doylestown Plus and GALAD, in detecting hepatocellular carcinoma (HCC) in patients with cirrhosis. Both panels demonstrated high sensitivity for any-stage and early-stage HCC detection, outperforming traditional methods like ultrasound and AFP. The findings suggest that these biomarker panels could significantly improve early HCC detection and patient outcomes.

Author

oviedomauricio02

Language

EN